IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
Total Assets Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Total Assets
kr177.1m
CAGR 3-Years
-22%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Total Assets
kr1.7B
CAGR 3-Years
14%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Total Assets
kr3.4B
CAGR 3-Years
49%
CAGR 5-Years
41%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Total Assets
kr10B
CAGR 3-Years
56%
CAGR 5-Years
136%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Total Assets
kr634.7m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Total Assets
kr4.4B
CAGR 3-Years
107%
CAGR 5-Years
142%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Total Assets?
Total Assets
177.1m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Total Assets amounts to 177.1m SEK.

What is IRLAB Therapeutics AB's Total Assets growth rate?
Total Assets CAGR 5Y
-5%

Over the last year, the Total Assets growth was -45%. The average annual Total Assets growth rates for IRLAB Therapeutics AB have been -22% over the past three years , -5% over the past five years .

Back to Top